Transferring Lessons from IgAN, FSGS & Membranous Nephropathy to Build Faster Approval Pathways Across Rare Kidney Disease
1:30 pm - Tuesday 16th March 2027
- Comparing where proteinuria, eGFR and disease-specific biomarkers have successfully supported approval
- Examining why surrogate strategies cannot automatically be transferred between kidney diseases
- Applying lessons from successful rare renal programs to PKD, Alport syndrome and less-developed indications